This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
On a day where we saw a relatively strong Retail Sales report for the month of June, it shouldn't come as too much of a surprise that Retailing is the best-performing Industry Group YTD and also trading the most above its 200-DMA. Given the recent strength, we wanted to quickly look into which stocks in the group have been doing the best this year. As regular readers are aware, non-traditional stocks like Amazon.
DLTR AMZN TRIP NFLX GPS LB LKQ
Amazon (AMZN - Free Report) is leaving no stone unturned to fortify presence in the healthcare sector. Reportedly, the company is in talks with a Seattle-based start-up called Xealth to work on a project related to medical supplies. Notably, the start-up assists the patients to manage their health with the aid of its digital health tools and prescriptions. The pilot project also welcomes the participation of two hospitals namely Providence Health Systems and University of Pittsburgh Medical Center.
BRK.A EXPE CTRP TRIP SAM
Tripadvisor (NASDAQ:TRIP) has released its list of the best burger joints in the U.S. and one location in Chapel Hill took the top spot.
June 29 - Financial Times (Peter Wells): "The buck is back. Tighter domestic monetary policy and global trade turmoil have set the US dollar for its best quarterly performance since December 2016. The DXY index, which tracks the US currency against a weighted basket of global peers, was up 5.2% in the three months to June 29. That has been achieved via a three-month winning streak, its first such run since December 2016, too.
BBDO CHKVP UAA MS.PRE MS.PRF MS.PRG CHKVZ MS.PRA SCGLF TWTR MS CHK.PRD CICHF CCB SCGLY TYT BDORY CMG BBD VLKAF NDAQ MS.PRI CHK MS.PRK 7203 SFUN GLE FB DB TIF HES TM NFLX AMD CBQS CHKDH CHKDG FMCKI FMCKJ CHKDJ KR ESV CHKDP ACA 0939 CKRGZ FMCCO FMCCP HYUO FMCCM FMCCN 55BC TRIP FMCCI ITUB FMCCJ M FMCCG FMCKO NYTAB FMCKP FMCKM CRARF TOYOF FMCKN FMCKK HYUD FMCKL CHKWZ DO CICHY UA ING OAS FMCC CHK.WI TSLA HYUP CRARY FMCCS FMCCT
In a bid to fortify presence in the world of e-books, Amazon (AMZN - Free Report) has added a vast repertoire of Arabic books on its reading device, Kindle. With the latest move, the company intends to cater to the growing global demand for Arabic books among Arabic readers as well as other readers. The company has added more than 12k books to its Kindle store which is in sync with the expansion of Amazon’s e-books portfolio.
EXPE TRIP WMT
The Nasdaq Composite, Nasdaq 100, small cap Russell 2000, Value Line Arithmetic and the NYSE Arca Biotechnology were among U.S. indices trading to all-time highs during Wednesday's session. In the real world, there is escalating risk of a destabilizing global trade war. The Shanghai Composite sank 4.4% this week to two-year lows. It was another week of instability for emerging market equities, bonds and currencies - especially in Asia.
LOW SYMC SIG AKRX KMX CHKVP UAA RL TWX CHKVZ SAM ASNA GM.WS.A TWTR GM.WS.B GM.WS.C CHK.PRD RCII CMCSK TWC FOSL NDAQ NTXFF CHK FL GM.WSB BA HBI CCV CONN NFLX AMD CCZ NTXFY CHKDH CHKDG FMCKI FMCKJ CHKDJ KR CHKDP BOE AAPL KSS SWN GM CKRGZ FMCCO FMCCP FMCCM FMCCN CMCSA TRIP FMCCI FMCCJ CVNA M FMCCG FMCKO NYTAB FMCKP FMCKM IWM FMCKN FMCKK FMCKL CHKWZ SIG W UA LHHMQ FMCC MU CCV.CL CHK.WI TSLA KN MNK GNW FIVE FMCCS FMCCT
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to TRIP / TripAdvisor, Inc. on message board site Silicon Investor.
as of ET